ARS Pharmaceuticals's market cap is currently $1.14B. The company's EPS TTM is $-0.507; its P/E ratio is ―; ARS Pharmaceuticals is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 30.00K	$ 1.32M	$ 5.51M	$ 17.84M	$ 0.00
Gross Profit	$ -43.00K	$ -16.00M	$ -14.77M	$ 3.77M	$ -1.55M
Operating Income	$ -67.52M	$ -35.52M	$ -19.45M	$ -469.00K	$ -24.07M
EBITDA	$ -67.45M	$ -35.52M	$ -19.24M	$ -463.00K	$ -22.52M
Net Income	$ -54.37M	$ -33.99M	$ -20.24M	$ -1.06M	$ -23.97M
Balance Sheet
Cash & Short-Term Investments	$ 228.36M	$ 274.38M	$ 60.06M	$ 24.52M	$ 9.98M
Total Assets	$ 233.19M	$ 281.44M	$ 61.45M	$ 26.41M	$ 15.65M
Total Debt	$ 274.00K	$ 481.00K	$ 9.03M	$ 10.02M	$ 15.62M
Net Debt	$ -70.70M	$ -210.04M	$ -51.03M	$ -14.50M	$ 5.64M
Total Liabilities	$ 2.43M	$ 8.55M	$ 92.72M	$ 40.46M	$ 21.25M
Stockholders' Equity	$ 230.76M	$ 272.89M	$ -31.27M	$ -14.05M	$ -5.60M
Cash Flow
Free Cash Flow	$ -59.44M	$ -40.28M	$ -17.62M	$ 8.15M	$ -18.99M
Operating Cash Flow	$ -59.27M	$ -40.08M	$ -17.56M	$ 9.07M	$ -18.90M
Investing Cash Flow	$ -87.18M	$ -199.00K	$ -55.00K	$ -917.00K	$ -96.00K
Financing Cash Flow	$ 6.90M	$ 190.73M	$ 53.16M	$ 5.10M	$ 8.61M

Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

Income Statement >

ARS Pharmaceuticals Debt to Assets

Balance Sheet >

ARS Pharmaceuticals Cash Flow

Cash Flow >

ARS Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing